Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease.
Yoshimasa HoshikawaNoriyuki KawamiShintaro HoshinoTomohide TanabeMariko UmezawaMitsuru KaiseKatsuhiko IwakiriPublished in: Esophagus : official journal of the Japan Esophageal Society (2019)
On-demand therapy with 20-mg vonoprazan exerted equivalent effects to continuous PPI maintenance therapy for patients with non-erosive reflux disease.